Education
About Us
Working with TipRanks
Follow Us
IM Cannabis Corp (IMCC)
NASDAQ:IMCC
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.68 - $7.12
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$3.57M
Enterprise Value$32.03M
Total Cash (Recent Filing)$1.18M
Total Debt (Recent Filing)$17.56M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.54
Shares Outstanding5,246,812
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio-0.55
Price to Book (P/B)1.50
Price to Sales (P/S)0.15
P/FCF Ratio-6.38
Enterprise Value/Market Cap8.98
Enterprise Value/Revenue0.61
Enterprise Value/Gross Profit2.61
Enterprise Value/Ebitda-14.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Market Position (Israel & Germany)IM Cannabis’s concentrated presence in regulated, higher‑barrier medical markets (Israel and Germany) creates durable demand from patients and healthcare channels. These markets favor licensed suppliers, support pricing stability versus commoditized markets, and underpin long‑term revenue potential if execution holds.
Access To FinancingThe US$2.17M convertible note financing reduced near‑term creditor pressure and funded working capital, demonstrating the company can secure institutional capital. While potentially dilutive, this financing provides runway to stabilize operations and execute strategic initiatives over the next 12–18 months.
Management StrengtheningHiring a CFO with ~15 years of finance and controlling experience should improve financial controls, budgeting and capital allocation. Stronger finance leadership can durably enhance cash management, refinancing efforts and operational efficiency during a multi‑quarter turnaround.
Bears Say
High LeverageTTM debt materially exceeding equity (debt/equity >3x) raises solvency and refinancing risk. High leverage limits strategic flexibility, increases interest burdens, and amplifies downside from operational setbacks, making sustained investment or acquisitions more difficult without deleterious dilution or restructuring.
Negative Cash GenerationPersistent negative operating and free cash flow indicates ongoing cash burn and reliance on external financing. Without a durable shift to positive cash generation, the company will remain dependent on dilutive or costly capital, constraining reinvestment and increasing execution risk over the medium term.
Weak Profitability & Thin MarginsMid‑to‑high teens gross margins and continued operating losses suggest the business lacks margin resilience against input cost pressure and competitive pricing. This structural margin weakness slows the path to sustainable profitability and limits the company’s ability to self‑fund growth or cushion downturns.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.68 and its highest was $7.12 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $3.57M.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is Mar 26, 2026 which is in 23 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on Nov 13, 2025. The company reported -$0.535 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.535.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 5,246,812 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.535 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.028%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
54.57% Insiders
3.15% Other Institutional Investors
40.35% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---